Shu Lin, Gu Jinjie, Wang Qinghui, Sun Shaoqi, Cui Youtian, Fell Jason, Mak Wai Shun, Siegel Justin B, Shi Jiping, Lye Gary J, Baganz Frank, Hao Jian
Lab of Biorefinery, Shanghai Advanced Research Institute, Chinese Academy of Sciences, No. 99 Haike Road, Pudong, Shanghai, 201210, People's Republic of China.
University of Chinese Academy of Sciences, Beijing, 100049, People's Republic of China.
Biotechnol Biofuels Bioprod. 2022 May 2;15(1):41. doi: 10.1186/s13068-022-02144-8.
Klebsiella pneumoniae contains an endogenous isobutanol synthesis pathway. The ipdC gene annotated as an indole-3-pyruvate decarboxylase (Kp-IpdC), was identified to catalyze the formation of isobutyraldehyde from 2-ketoisovalerate.
Compared with 2-ketoisovalerate decarboxylase from Lactococcus lactis (KivD), a decarboxylase commonly used in artificial isobutanol synthesis pathways, Kp-IpdC has an 2.8-fold lower K for 2-ketoisovalerate, leading to higher isobutanol production without induction. However, expression of ipdC by IPTG induction resulted in a low isobutanol titer. In vitro enzymatic reactions showed that Kp-IpdC exhibits promiscuous pyruvate decarboxylase activity, which adversely consume the available pyruvate precursor for isobutanol synthesis. To address this, we have engineered Kp-IpdC to reduce pyruvate decarboxylase activity. From computational modeling, we identified 10 amino acid residues surrounding the active site for mutagenesis. Ten designs consisting of eight single-point mutants and two double-point mutants were selected for exploration. Mutants L546W and T290L that showed only 5.1% and 22.1% of catalytic efficiency on pyruvate compared to Kp-IpdC, were then expressed in K. pneumoniae for in vivo testing. Isobutanol production by K. pneumoniae T290L was 25% higher than that of the control strain, and a final titer of 5.5 g/L isobutanol was obtained with a substrate conversion ratio of 0.16 mol/mol glucose.
This research provides a new way to improve the efficiency of the biological route of isobutanol production.
肺炎克雷伯菌含有一条内源性异丁醇合成途径。被注释为吲哚 - 3 - 丙酮酸脱羧酶(Kp - IpdC)的ipdC基因,被鉴定可催化2 - 酮异戊酸形成异丁醛。
与乳酸乳球菌的2 - 酮异戊酸脱羧酶(KivD)相比,KivD是人工异丁醇合成途径中常用的脱羧酶,Kp - IpdC对2 - 酮异戊酸的K值低2.8倍,导致在无诱导的情况下异丁醇产量更高。然而,通过IPTG诱导表达ipdC导致异丁醇滴度较低。体外酶促反应表明,Kp - IpdC表现出混杂的丙酮酸脱羧酶活性,这不利地消耗了用于异丁醇合成的可用丙酮酸前体。为了解决这个问题,我们对Kp - IpdC进行了改造以降低丙酮酸脱羧酶活性。通过计算建模,我们确定了活性位点周围的10个氨基酸残基用于诱变。选择了由8个单点突变体和2个双点突变体组成的10种设计进行探索。与Kp - IpdC相比,对丙酮酸催化效率仅为5.1%和22.1%的突变体L546W和T290L,随后在肺炎克雷伯菌中表达以进行体内测试。肺炎克雷伯菌T290L的异丁醇产量比对照菌株高25%,以0.16 mol/mol葡萄糖的底物转化率获得了5.5 g/L异丁醇的最终滴度。
本研究为提高异丁醇生物合成途径的效率提供了一种新方法。